A lead analyst at AMR highlighted that the varicella live vaccine market in Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period.
Allied Market Research published a research report on the varicella live vaccine market. The findings of the report state that the global market for varicella live vaccine generated $2.71 billion in 2018, and is expected to reach $4.22 billion by 2026, registering a CAGR of 5.7% from 2019 to 2026. The report offers valuable information on changing market dynamics, major segments, top investment pockets, and competitive scenarios for market players, investors, shareholders, and new entrants.
Get a PDF Sample:
The report provides detailed insights on drivers, restraints, and opportunities to help the market players in devising several growth strategies. An increase in awareness towards the use of varicella live vaccines and a surge in immunization programs in various countries across the globe are expected to drive the growth of global varicella live vaccine market. On the other hand, high monetary inputs associated with the production of the products are expected to hinder the growth of the market to some extent. However, immense growth potential and an increase in investment in the research and biotechnology sector are expected to create ample opportunities for the industry.
Download Sample Report:
“The demand for varicella live vaccines is on a rise, owing to the rise in immunization programs and a surge in awareness related to the use of varicella live vaccine worldwide. Furthermore, rise in the adoption of varicella live vaccines among healthcare providers fuels the market growth,” says Onkar Sumant Manager, of Healthcare at Allied Market Research.
The report offers detailed segmentation of the global varicella live vaccine market based on product, application, provider, and region. These insights are helpful for new as well as existing market players to capitalize on the fastest-growing and largest revenue-generating segments to accomplish growth in the future.
Based on product, the monovalent varicella vaccine segment held the largest market share in 2018, holding nearly two-thirds of the global market. In addition, the same segment is expected to cite the fastest CAGR of 5.9% during the forecast period. The report also analyses other segments of the market such as the Combination Varicella Vaccine segment.
Based on application, the chickenpox immunization segment held the dominating market share in 2018, holding nearly three-fifths of the global market. The herpes zoster segment, on the other hand, is projected to register the fastest CAGR of 9.8% during the forecast period.
Based on region, the market across North America held the dominating market share in 2018, holding more than two-fifths of the global market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 7.0% during the forecast period.
The key players analyzed in the global varicella live vaccine market report include Bio-Med Pvt. Limited, Changchun BCHT Biotechnology Co. Ltd., Emcure Pharmaceuticals Limited, GlaxoSmithKline plc, Green Cross Holdings (GC Pharma), Merck & Co. Inc., Mitsubishi Chemical Holdings Corporation (Mitsubishi Tanabe Pharma Corporation), Novo Medi Sciences Pvt. Ltd., Sanofi, and Takeda Pharmaceutical Company Limited.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to offer business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060|Fax: +1-855-550-5975
Follow us on LinkedIn, Twitter, Facebook, Pinterest, YouTube & Instagram.